NCT03214211

Prospective Observational Study of Pravafenix Cap

Assess the Long-term Safety and Efficacy of Pravafenix Cap. in Korean Patients With Dyslipidemia: a Multicenter, Prospective, Observational Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 3,088 (estimated)
• Sponsor: Yooyoung Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

To observe the effiacay, safety and risk of developing diabetes, review the patients chars who had administrated or neet to administrate the Pravafenix cap for enroll period, it is an prospective observational study that only collect the collectable information follwoing the hospital visiting date from enroll point to information collecting date. There is no extra visit for this study. Observe the data which has been collected for 3 yearts every year from enroll point, if the patients agree to be participated in this study and are suitable in inclusion/exclusion criteria. If the lipid-lowering drugs(only Ezetimibe is possible) is add-on the Pravafenix Cap administrating period, it will be analyzed by laering analysis separately. But, the reason why it is add-on to have to be written on e-CRF.

Conditions

• Dyslipidemias

Timeline

• Start date: 2017-08-30
• Primary completion: 2022-06-30
• Completion: 2022-06-30
• First posted: 2017-07-11
• Last updated: 2017-08-31

Locations

1 site across 1 country: South Korea